APR 11, 2016 8:53 AM PDT

3D ‘Pen' Prints Cartilage Implants from Stem Cells

WRITTEN BY: Xuan Pham
Handheld 3D printer: Surgeon's new tool?
As three-dimensional (3D) printing continues to gain momentum in the field of bioengineering, the challenge now is integrating the technology directly with patient care. Addressing this need, researchers from St Vincent's Hospital, Melbourne, Australia, designed a compact, handheld 3D printing “Biopen” that can make cartilage implants during live operations.
 
Another innovation in the 3D printing Biopen is the ink it uses to print. Instead of synthetic polymers, the handheld device uses a bio-ink containing live human stem cells suspended in a gelatin-based hydrogel solution. As the “ink” is extruded, an ultraviolet light source cross-links the material, hardening it and enabling it to be surgically sculpted into 3D structures.
 
Remarkably, the research team reported high cell survivability, greater than 97 percent, after one week in live cultured experiments using human adipose stem cells. So far the bio-pen serves as a proof-of-concept; it has not yet been used in surgeries yet, but the research team is gearing up for this next, as the biggest advantage of the device is its application in live operation theaters.
 

In few instances in medical procedures are doctors able to use generic pre-printed structures as-is. Most often, the product has to be customized to fit the patient’s unique body plan and shape. This is especially true for artificial cartilage repair surgeries, where doctors can’t even fabricate a pre-printed structure prior to knowing the patient’s exact body geometry. Thus, a handheld printer could truly revolutionize the precision and speed of artificial cartilage implants.
 
With open surgery in mind, the research team made the device out of medical grade plastic and titanium. These materials make the Biopen lightweight and easy to handle, as well as easy to sterilize. Fitting in the one hand, the device seamlessly integrates into surgeries without disruption to doctors’ procedural flow.
 
“The Biopen described in this study paves the way for the use of 3D bioprinting during the surgical process,” the authors wrote. “The ability to directly control the deposition of regenerative scaffolds with or without the presence of live cells during the surgical process presents an exciting advance not only in the fields of cartilage and bone regeneration but also in other fields where tissue regeneration and replacement are critical.”

Additional source: Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 05, 2020
Clinical & Molecular DX
Painless Microneedle Patch Diagnoses Malaria in Minutes
NOV 05, 2020
Painless Microneedle Patch Diagnoses Malaria in Minutes
It looks like a Band-Aid — a small, adhesive patch that is applied directly to the skin. This simple, low-cost dia ...
NOV 13, 2020
Chemistry & Physics
Mid-IR Spectroscopy a Convenient, Accurate Means of Cancer Diagnosis
NOV 13, 2020
Mid-IR Spectroscopy a Convenient, Accurate Means of Cancer Diagnosis
Last Sunday, November 8, was the International Day of Radiology (IDoR 2020), an event celebrated by radiologists, techno ...
DEC 01, 2020
Clinical & Molecular DX
Breathing New Life Into COVID Diagnostics
DEC 01, 2020
Breathing New Life Into COVID Diagnostics
Widespread diagnostic testing capacities are an absolutely critical tool for countries battling the pandemic. For now, m ...
DEC 24, 2020
Clinical & Molecular DX
Feeling Unmotivated? It Could Be Dementia.
DEC 24, 2020
Feeling Unmotivated? It Could Be Dementia.
Apathy, characterized by a pronounced lack of enthusiasm, motivation, or interest, is a predictor of the future onset of ...
JAN 06, 2021
Clinical & Molecular DX
COVID Patients Can't Stop and Smell the Roses
JAN 06, 2021
COVID Patients Can't Stop and Smell the Roses
A study of over 2,500 European patients has revealed that 85.9 percent of those with mild COVID-19 symptoms lost their s ...
MAR 02, 2021
Clinical & Molecular DX
Splice and Dice: Zeroing in on Rare Gene Variants in Alzheimer's
MAR 02, 2021
Splice and Dice: Zeroing in on Rare Gene Variants in Alzheimer's
DNA is the four-letter language that codes for genes, “paragraphs” of DNA information that carry specific in ...
Loading Comments...